This inventor holds 1 USPTO granted patent. Top assignees: Teijin Pharma Limited, The University of Tokyo. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011
Title: Ichiro Takada: Innovator in Vitamin D Research
Introduction
Ichiro Takada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of vitamin D research, particularly through his innovative patent that focuses on screening methods for vitamin D receptor ligands. His work has implications for therapeutic agents aimed at enhancing bone health.
Latest Patents
Ichiro Takada holds a patent titled "Method for screening for vitamin D receptor ligands." This invention relates to a screening method for a compound and includes a step of detecting binding between a vitamin D receptor and CDP. The method enables in vitro screening of compounds that exhibit strong bone-forming action with minimal side effects. It also facilitates the identification of compounds that participate in osteoblast differentiation. The patent provides a therapeutic agent containing the compound for diseases that interfere with vitamin D-mediated transcriptional activity, as well as a kit for performing the screening method.
Career Highlights
Throughout his career, Ichiro Takada has worked with notable organizations, including Teijin Pharma Limited and The University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in medical research.
Collaborations
Ichiro Takada has collaborated with esteemed colleagues such as Eiji Ochiai and Kazuyoshi Yamaoka. These partnerships have enriched his research and expanded the impact of his innovations in the scientific community.
Conclusion
Ichiro Takada's contributions to vitamin D research through his innovative patent demonstrate his commitment to advancing medical science. His work not only enhances our understanding of bone health but also paves the way for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile